Hussain Almasmoum

8PUBLICATIONS
33CO-AUTHORS
Characterisation of biological macromoleculesMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Pharmaceutical delivery technologiesPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 22, 2026
Metabolomics-guided network pharmacology and molecular modeling suggest bioactive components of Chiliadenus montanus associated with multi-target anticancer and anti-inflammatory activities.

|Jul 15, 2025
Synthesis and multi-target antiproliferative evaluation of novel 1,2,4-triazole-3-thione analogues against breast cancer: in silico and in vitro mechanistic insights.

Hussain Ali Almasmoum, Ghassan Almaimani, Riyad A Almaimani

|Jan 23, 2024
Predictive Factors for Critical Weight Loss in Saudi Head and Neck Cancer Patients Undergoing (Chemo)Radiotherapy.

Alaa S Redwan, Fayrooz A Kattan, Maha A Alidrisi

|Dec 23, 2023
Improved Glycaemic Control and Nephroprotective Effects of Empagliflozin and Paricalcitol Co-Therapy in Mice with Type 2 Diabetes Mellitus.

Abdulrahman Mujalli, Wesam F Farrash, Ahmad A Obaid

|Mar 25, 2022
In Vivo and In Vitro Enhanced Tumoricidal Effects of Metformin, Active Vitamin D3, and 5-Fluorouracil Triple Therapy against Colon Cancer by Modulating the PI3K/Akt/PTEN/mTOR Network.

Riyad Adnan Almaimani, Akhmed Aslam, Jawwad Ahmad

|Apr 22, 2021
Potential Predictors of Poor Prognosis among Severe COVID-19 Patients: A Single-Center Study.

Mazen M Ghaith, Mohammad A Albanghali, Abdullah F Aldairi

Pageof 2

Frequent Collaborators

3 joint publications

Riyad Adnan Almaimani

2 joint publications

Mohammad Albanghali

2 joint publications

Mazen M Ghaith

2 joint publications

Akhmed Aslam